Results 1 to 10 of about 112,827 (251)

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Undergoing Aortic Valve Replacement for Severe Aortic Stenosis: A Retrospective Cohort Study. [PDF]

J Clin Med
Abid H, Khan Y, Khan N, Khan J, Steeds RP.   +4 more
europepmc   +1 more source

Angiotensin converting enzyme inhibitors and angiotensin receptor blockers impact on the gut microbiome: a systematic review. [PDF]

Front Endocrinol (Lausanne)
Wang EM, Shremo Msdi A, Quach VN, Nguyen SQ, Quach E, Jo J, Eubank TA, Garey KW, Rosario N.   +8 more
europepmc   +1 more source

The use of angiotensin-converting enzyme inhibitors in hospitalized patients with COVID-19 is associated with a lower risk of mortality. [PDF]

Sci Rep
Khalangot M, Gurianov V, Zakharchenko T, Kravchenko V, Kovzun O, Shupachynskiy V, Tronko M.   +6 more
europepmc   +1 more source

Machine Learning Approaches to Investigate the Structure-Activity Relationship of Angiotensin-Converting Enzyme Inhibitors. [PDF]

ACS Omega, 2023
Yu T, Nantasenamat C, Anuwongcharoen N, Piacham T.   +3 more
europepmc   +1 more source

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers for Cardiovascular and Renal Protection in Type 2 Diabetes: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Alqurain A, Alotaibi MA, Alazmi BA, Aljohani MA, Albalawi BR, Alzughaibi DA, Alzhrani AF, Ahmed RE, Alnoumesy HN, Aloufi SA, Al Jarad AA, Alqarni RS, Almoqati HM, Mashhour MA, Alzahrani AA.   +14 more
europepmc   +1 more source

Direct Renin Inhibition With Aliskiren Compared to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension: A Systematic Review. [PDF]

Cureus
Gapizov A, Mohammad A, Singla S, Singla B, Kumawat S, Ajay, Ali Z.   +6 more
europepmc   +1 more source

Response and survival of dogs with proteinuria (UPC > 2.0) treated with angiotensin converting enzyme inhibitors. [PDF]

J Vet Intern Med, 2023
Fulton EA, McBrearty AR, Shaw DJ, Ridyard AE.   +3 more
europepmc   +1 more source

Angiotensin converting enzyme inhibitors (ACEIs) for anthracycline-induced cardiotoxicity: a systematic review and meta-analysis of randomized controlled trials. [PDF]

Ann Saudi Med
Safwan M, Bourgleh MS, AlShakaki H, Haider KH.   +3 more
europepmc   +1 more source

Decreased potential for lymphatic vessel generation is a hallmark of early diagnosed arterial hypertension and can be reversed by treatment with angiotensin converting enzyme inhibitors. [PDF]

Sci Rep
Gliwiński M, Koliński T, Urban-Wójciuk Z, Zieliński M, Piekarska K, Fraściszewska M, Żyłko A, Pęksa R, Karczewska J, Peszyńska-Sularz G, Trzeciak B, Molisz A, Gutknecht P, Reiwer-Gostomska M, Pietrzykowska M, Iwaszkiewicz-Grześ D, Biernat W, Glasner P, Glasner L, Chruściel E, Trzonkowski P, Siebert J, Marek-Trzonkowska NM.   +22 more
europepmc   +1 more source

Association Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Antivascular Endothelial Growth Factor-Related Proteinuria in Solid Tumors: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Ohta R, Fujimori T, Tanaka K, Hayashi H.
europepmc   +1 more source